Involvement of the Endocannabinoid System in Motor Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|4|3|175-182

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.4, Iss.3, 2004-09, pp. : 175-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the endocannabinoid system in treating brain disorders

By Bahr Ben A   Karanian David A   Makanji Sagar S   Makriyannis Alexandros  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 351-365

Informa Healthcare

Access to resources Recommend Favorite

The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 451-458

Bentham Science Publishers

Access to resources Recommend Favorite

Cat odour-induced anxiety—a study of the involvement of the endocannabinoid system

By Sütt Silva   Raud Sirli   Areda Tarmo   Reimets Ain   Kõks Sulev   Vasar Eero  

Psychopharmacology, Vol. 198, Iss. 4, 2008-07 ,pp. : 509-520

Springer Publishing Company

Access to resources Recommend Favorite

The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence

By  

Current Pharmaceutical Design, Vol. 20, Iss. 13, 2014-04 ,pp. : 2089-2099

Bentham Science Publishers

Access to resources Recommend Favorite

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

By van der Stelt M.   Di Marzo V.  

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 133-150

Elsevier

Access to resources Recommend Favorite